Clinical Trial Supplies Global Market to Reach $5.7 Billion by 2027 at a CAGR of 9.7% – QNT Press Release


DUBLIN, Nov. 24, 2022 /PRNewswire/ — The “Clinical Trial Supplies Market by Services (Manufacturing, Packaging, Logistics), Phases (I to IV), Type (Small Molecules, Biologics), Therapeutic Areas (Oncology, CVD, Infectious, Immunology), End User (Pharma, Biotech, CROs ) – Global Forecast 2027” report has been added to ResearchAndMarkets.com’s offering.

The Global Clinical Trial Supplies market is projected to reach USD 5.7 billion by 2027 from USD 3.6 billion in 2022, at a CAGR of 9.7% during the forecast period of 2022 to 2027. Factors such a as globalization of clinical trials and growing R&D expenditure in pharmaceutical and biopharmaceutical companies are driving the market.

The logistics and distribution segment accounted for the highest growth rate in the clinical trial supplies market, by service, during the forecast period

In 2021, the logistics & distribution services segment accounted for the largest share of the clinical trial supplies market. Factors such as the globalization of clinical trials, expertise of supply companies in terms of therapeutic areas and geographic reach and …

Full story available on Benzinga.com



Source link

Recommended For You

About the Author: News Center